Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multispectral Optoacoustic Tomography for Translational Molecular Imaging in Pompe Disease

NCT05083806 is registered in ClinicalTrials.gov with University of Erlangen-Nürnberg Medical School as lead sponsor.

NCT NCT05083806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05083806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multispectral Optoacoustic Tomography for Translational Molecular Imaging in Pompe Disease
Lead sponsor
University of Erlangen-Nürnberg Medical School
Phase
Not applicable
Overall status
Completed
Start date
May 17, 2022
Completion date
August 14, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pompe disease, pompe disease (late-onset), pompe disease infantile-onset, pompe's disease juvenile onset